Resources

COVID-19 Vaccination Planning

Product: — Evidence Synthesis Network

Future Planning Models Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: November 6, 2020

Best Practices for Knowledge Translation Of Public Health/Epidemiological Information to Health Sector Leaders and Decision Makers

Product: — Evidence Synthesis Network

Communication Practices Communications & Media Public Health Policy Regulation & Policy

esnetwork.ca Last Updated: October 23, 2020

Synopsis of Reference Search Results for Topics in Long-Term Care

Product: — Canadian Agency for Drugs and Technologies in Health

Long-term & Community Care Long-term Care

covid.cadth.ca Last Updated: October 21, 2020

Also available in Français

Impacts on Quadruple-Aim Metrics of Long-Term Care Facility Visitor Restrictions

Product: — Evidence Synthesis Network

Communications & Media Community Prevention & Transmission Infection Control Guidelines Long-term & Community Care Long-term Care

esnetwork.ca Last Updated: September 24, 2020

Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing

Product: — Science Table

Immune System Serological Testing Testing & Tracing Vaccines & Immunity

covid19-sciencetable.ca Last Updated: August 12, 2020

Ongoing Trials for Novel Vaccines in the Prevention of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Vaccine Vaccines & Immunity

covid.cadth.ca Last Updated: August 10, 2020

Also available in Français

Ongoing Trials for Bacille Calmette-Guérin (BCG) Vaccines in the Prevention of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Vaccine Vaccines & Immunity

covid.cadth.ca Last Updated: August 10, 2020

Also available in Français

Needleless Injectors for the Administration of Vaccines: A Review of Clinical Effectiveness

Product: — Canadian Agency for Drugs and Technologies in Health

Vaccine Vaccines & Immunity

covid.cadth.ca Last Updated: July 17, 2020

Also available in Français

Influenza Vaccination and Risk of Subsequent Non-Influenza Respiratory Viruses: Safety

Product: — Canadian Agency for Drugs and Technologies in Health

Vaccine Vaccines & Immunity

covid.cadth.ca Last Updated: June 8, 2020

Also available in Français